These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9789710)

  • 61. Regional brain monoamines and their metabolites after portacaval shunting.
    Mans AM; Consevage MW; DeJoseph MR; Hawkins RA
    Metab Brain Dis; 1987 Sep; 2(3):183-93. PubMed ID: 2463462
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Venlafaxine: acute and chronic effects on 5-hydroxytryptamine levels in rat brain in vivo.
    Gur E; Dremencov E; Lerer B; Newman ME
    Eur J Pharmacol; 1999 May; 372(1):17-24. PubMed ID: 10374710
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evidence of the dual mechanisms of action of venlafaxine.
    Harvey AT; Rudolph RL; Preskorn SH
    Arch Gen Psychiatry; 2000 May; 57(5):503-9. PubMed ID: 10807491
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacokinetics of venlafaxine and its major metabolite o-desmethylvenlafaxine in freely moving mice using automated dosing/sampling system.
    Aryal B; Aryal D; Kim EJ; Kim HG
    Indian J Pharmacol; 2012 Jan; 44(1):20-5. PubMed ID: 22345864
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex.
    Bymaster FP; Zhang W; Carter PA; Shaw J; Chernet E; Phebus L; Wong DT; Perry KW
    Psychopharmacology (Berl); 2002 Apr; 160(4):353-61. PubMed ID: 11919662
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Discrepancies between the in vitro and in vivo 5-HT and norepinephrine re-uptake blocking properties of venlafaxine.
    Béïque JC; Debonnel G; de Montigny C; Blier P
    Ann N Y Acad Sci; 1998 Dec; 861():290-1. PubMed ID: 9928296
    [No Abstract]   [Full Text] [Related]  

  • 67. Effect of venlafaxine dosage, valproic acid concentration, sex, and age on steady state dose-corrected concentrations of venlafaxine and O-desmethylvenlafaxine: A retrospective analysis of therapeutic drug monitoring data in a Chinese population.
    Wang ZZ; Deng SH; Lu HY; Li L; Zhu XQ; Hu JQ; Xie HS; Chen HZ; Chen YQ; Zhang M; Fang ZY; Wen YG; Shang DW
    Hum Psychopharmacol; 2020 May; 35(3):e2733. PubMed ID: 32239743
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Increased brain serotonin turnover correlates with the degree of shunting and hyperammonemia in rats following variable portal vein stenosis.
    Lozeva V; Montgomery JA; Tuomisto L; Rocheleau B; Pannunzio M; Huet PM; Butterworth RF
    J Hepatol; 2004 May; 40(5):742-8. PubMed ID: 15094220
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Brain monoamine metabolism and behavior in portacaval-shunted rats.
    Bengtsson F; Gage FH; Jeppsson B; Nobin A; Rosengren E
    Exp Neurol; 1985 Oct; 90(1):21-35. PubMed ID: 2412877
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Content of quinolinic acid and of other tryptophan metabolites increases in brain regions of rats used as experimental models of hepatic encephalopathy.
    Moroni F; Lombardi G; Carlà V; Pellegrini D; Carassale GL; Cortesini C
    J Neurochem; 1986 Mar; 46(3):869-74. PubMed ID: 2419500
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Influence of CYP2D6 genotype on the disposition of the enantiomers of venlafaxine and its major metabolites in postmortem femoral blood.
    Kingbäck M; Karlsson L; Zackrisson AL; Carlsson B; Josefsson M; Bengtsson F; Ahlner J; Kugelberg FC
    Forensic Sci Int; 2012 Jan; 214(1-3):124-34. PubMed ID: 21840145
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Venlafaxine plus melatonin ameliorate reserpine-induced depression-like behavior in zebrafish.
    Tang YQ; Li ZR; Zhang SZ; Mi P; Chen DY; Feng XZ
    Neurotoxicol Teratol; 2019; 76():106835. PubMed ID: 31518687
    [TBL] [Abstract][Full Text] [Related]  

  • 73. PET neuroimaging with [11C]venlafaxine: serotonin uptake inhibition, biodistribution and binding in living pig brain.
    Smith DF; Jensen PN; Gee AD; Hansen SB; Danielsen E; Andersen F; Saiz PA; Gjedde A
    Eur Neuropsychopharmacol; 1997 Aug; 7(3):195-200. PubMed ID: 9213078
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex.
    Felton TM; Kang TB; Hjorth S; Auerbach SB
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):297-305. PubMed ID: 12644903
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Determination of serotonin, noradrenaline, dopamine and their metabolites in rat brain extracts and microdialysis samples by column liquid chromatography with fluorescence detection following derivatization with benzylamine and 1,2-diphenylethylenediamine.
    Yoshitake T; Kehr J; Yoshitake S; Fujino K; Nohta H; Yamaguchi M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Aug; 807(2):177-83. PubMed ID: 15203027
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Combination therapy with venlafaxine and carbamazepine in depressive patients not responding to venlafaxine: pharmacokinetic and clinical aspects.
    Ciusani E; Zullino DF; Eap CB; Brawand-Amey M; Brocard M; Baumann P
    J Psychopharmacol; 2004 Dec; 18(4):559-66. PubMed ID: 15582923
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Application of a first-pass effect model to characterize the pharmacokinetic disposition of venlafaxine after oral administration to human subjects.
    Taft DR; Iyer GR; Behar L; DiGregorio RV
    Drug Metab Dispos; 1997 Oct; 25(10):1215-8. PubMed ID: 9321527
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Preclinical pharmacology of TP1, a novel potent triple reuptake inhibitor with antidepressant properties.
    Tian JW; Jiang WL; Zhong Y; Meng Q; Gai Y; Zhu HB; Hou J; Xing Y; Li YX
    Neuroscience; 2011 Nov; 196():124-30. PubMed ID: 21925241
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Brain 5-HT1 and 5-HT2 binding sites following portacaval shunt in the rat.
    Bengtsson F; Bugge M; Hall H; Nobin A
    Res Exp Med (Berl); 1989; 189(4):249-56. PubMed ID: 2813962
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Simultaneous increases of extracellular monoamines in microdialysates from hypothalamus of conscious rats by duloxetine, a dual serotonin and norepinephrine uptake inhibitor.
    Engleman EA; Perry KW; Mayle DA; Wong DT
    Neuropsychopharmacology; 1995 Jul; 12(4):287-95. PubMed ID: 7576005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.